Australia to Ban Non-Prescription Vapes in Major Reform

May.02.2023
Australia to Ban Non-Prescription Vapes in Major Reform
Australia bans non-prescription e-cigarettes, sets quality standards, and invests $234 million in smoking reforms.

On May 1st, according to a report from The Guardian, Australian Health Minister Mark Butler announced that the government will ban the importation of non-prescription electronic cigarette products. The government will also establish minimum quality standards which will include restricting e-cigarette flavors, packaging colors, and other ingredients. Similar to pharmaceuticals, packaging will indicate reduced nicotine concentration and capacity. Additionally, single-use e-cigarettes will be explicitly prohibited.


Determined to eliminate the "public health threat".


A previous investigation was conducted by Australia's Therapeutic Goods Administration (TGA) on the regulation reform of e-cigarettes within the country. The majority of materials submitted by relevant health organizations supported increasing border control.


They believe that the focus of border control is on non-nicotine electronic cigarette products.


Electronic cigarette manufacturers have falsely labeled products containing nicotine as "nicotine-free" to circumvent import restrictions.


This makes it easy for children to buy electronic cigarettes and often unknowingly inhale nicotine, leading to addiction.


The Minister of Health, Mr. Butler, said in a television program that the tobacco industry is attempting to create a "new generation of nicotine addicts" through the production of e-cigarettes. He stated that he is determined to eliminate this public health threat.


The Australian government will collaborate with states and territories to put an end to the sale of electronic cigarettes in convenience stores and other retail shops. They will also establish stricter guidelines for the sale of e-cigarette products in pharmacies, in order to ensure the contents are safe for consumers.


The largest loophole in Australian history


Butler is expected to outline these reforms in a speech at the National Press Club. According to a leaked copy of the speech, Butler believes that e-cigarettes have become "the biggest loophole in Australian history" and has announced that the government will invest AUD 234 million (approximately RMB 1.07 billion) into reforms relating to tobacco and e-cigarettes.


The speech by Butler stated that electronic cigarettes are being marketed as a therapeutic product to governments and communities around the world to aid long-term smokers in quitting.


It was never intended to be sold as an entertainment product, especially not one suitable for our children. But that is what it has become: the biggest loophole in Australian history.


A sum of 63 million Australian dollars (approximately 289 million yuan) will be utilized for public health advocacy campaigns aimed at preventing smoking and the use of e-cigarettes while also promoting smoking cessation.


Additionally, 30 million Australian dollars (approximately 138 million Chinese yuan) will be invested in a support program to help Australians quit smoking, and there will be an increased effort to educate and train healthcare professionals on smoking cessation and nicotine addiction.


According to Terry Slevin, CEO of the Australian Public Health Association, the upcoming reforms by the Australian government describe electronic cigarettes as a "public health disaster". He stated that the reforms will make Australia a world leader in controlling tobacco and e-cigarettes.


Laura Hunter, joint CEO of the Australian Smoking and Health Council, says it is encouraging to see the government take decisive action against a harmful industry.


She stated that the government's plan is largely normalizing the culture of e-cigarettes.


Further reading:


Australia may implement a complete ban on imported electronic cigarettes.


An Australian state plans to broaden the scope of smoke-free public spaces and double fines for selling e-cigarettes to minors.


Australia to introduce plain packaging and flavor bans, and strengthen border control measures.


Reference list:


Australia is set to implement its most significant smoking reforms in a decade by banning the sale of non-prescription vapes.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
Wang Gongcheng, deputy administrator of China’s State Tobacco Monopoly Administration, met KT&G Chief Operating Officer Lee Sang-hak in Shanghai on September 1, according to Oriental Tobacco News. The meeting comes as China seeks public comment on a draft mandatory national standard for heated cigarettes. The report did not disclose the subjects discussed or indicate whether heated tobacco products or market access were addressed.
News
Sep.02
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Kuwait Tightens Tobacco and Nicotine Rules, Bans Under-21 Sales and Extends Public Smoking Restrictions to Vapes and Heated Tobacco
Kuwait Tightens Tobacco and Nicotine Rules, Bans Under-21 Sales and Extends Public Smoking Restrictions to Vapes and Heated Tobacco
Kuwait has issued a comprehensive new regulatory framework covering tobacco, e-cigarettes, heated tobacco and other nicotine products. Ministerial Decision No. 237 of 2026, signed by Health Minister Ahmad Al-Awadhi, will take effect on January 1, 2027. The rules prohibit sales to people under 21 and ban sales through websites, apps, social media and delivery services. E-cigarettes and heated tobacco products will also be treated as smoking in public and enclosed places where smoking is prohibited. Nicotine pouches and other oral nicotine products not registered as medicines are banned.
Regulations
Aug.17 by 2Firsts Perspectives